Peroxiredoxin III : a candidate for drug resistance to chemotherapy
2008 master's thesis by Miranda Aalderink at Massey University
Press Enter · cited answer in seconds
0 sources
Peroxiredoxin III : a candidate for drug resistance to chemotherapy
Summary
Peroxiredoxin III : a candidate for drug resistance to chemotherapy is a master's thesis[1].
Key Facts
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy authored a candidate for drug resistance to chemotherapy — author (P50): Miranda Aalderink[2].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's instance of is recorded as a candidate for drug resistance to chemotherapy — instance of (P31): master's thesis[3].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's publisher is recorded as a candidate for drug resistance to chemotherapy — publisher (P123): Massey Research Online[4].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's language of work or name is recorded as a candidate for drug resistance to chemotherapy — language of work or name (P407): English[5].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's country of origin is recorded as a candidate for drug resistance to chemotherapy — country of origin (P495): New Zealand[6].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's publication date is recorded as +2008-00-00T00:00:00Z[7].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's main subject is recorded as a candidate for drug resistance to chemotherapy — main subject (P921): physiological effect[8].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's main subject is recorded as a candidate for drug resistance to chemotherapy — main subject (P921): doxorubicin[9].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's main subject is recorded as a candidate for drug resistance to chemotherapy — main subject (P921): peroxidases[10].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's Handle ID is recorded as 10179/13302[11].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's title is recorded as Peroxiredoxin III : a candidate for drug resistance to chemotherapy[12].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's copyright holder is recorded as a candidate for drug resistance to chemotherapy — copyright holder (P3931): Miranda Aalderink[13].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's thesis submitted to is recorded as a candidate for drug resistance to chemotherapy — thesis submitted to (P4101): Massey University[14].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's on focus list of Wikimedia project is recorded as a candidate for drug resistance to chemotherapy — on focus list of Wikimedia project (P5008): NZThesisProject[15].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's copyright status is recorded as a candidate for drug resistance to chemotherapy — copyright status (P6216): copyrighted[16].
- Peroxiredoxin III : a candidate for drug resistance to chemotherapy's thesis committee member is recorded as a candidate for drug resistance to chemotherapy — thesis committee member (P9161): Kathryn Stowell[17].
Body
Designation and Status
Peroxiredoxin III : a candidate for drug resistance to chemotherapy's instance of is recorded as a candidate for drug resistance to chemotherapy — instance of (P31): master's thesis[3].